Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 3

Results: 21

ANTICANCER DRUGS: Overcoming inhibition.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 201, doi. 10.1038/nrd1354

By:

Frantz, Simon

Publication type:

Article

Double attack on patent for Wellbutrin sustained-release agent.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 196, doi. 10.1038/nrd1336
Publication type:: Article

Twenty questions Highlighting the pitfalls and possibilities of drug research.

Published in:

2004

By:

Ellis, Clare;
Smith, Adam

Publication type:

Editorial

Fresh from the pipeline: Omalizumab.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 199, doi. 10.1038/nrd1334

By:

Ames, Stephen A.;
Gleeson, Carole D.;
Kirkpatrick, Peter

Publication type:

Article

Neurodegenerative diseases and oxidative stress.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 205, doi. 10.1038/nrd1330

By:

Barnham, Kevin J.;
Masters, Colin L.

Publication type:

Article

Case history: Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 215, doi. 10.1038/nrd1331

By:

Matthews, Tom;
Saglo, Miklos;
Greenberg, Michael;
Chung, Jain;
DeMasi, Ralph;
Bolognesi, Dani

Publication type:

Article

Compensation for Japanese patent holders.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 196, doi. 10.1038/nrd1337
Publication type:: Article

Lack of descriptive support results in no interference-in-fact.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 196, doi. 10.1038/nrd1339
Publication type:: Article

Scientists slam rationale behind largest HIV vaccine trial.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 195, doi. 10.1038/nrd1359

By:

Frantz, Simon

Publication type:

Article

NEWS IN BRIEF.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 194
Publication type:: Article

Aventis-Sanofi: a good R&D merger?

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 193, doi. 10.1038/nrd1358

By:

Frantz, Simon

Publication type:

Article

First dose of potential new medicines to humans: how animals help.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 226, doi. 10.1038/nrd1329

By:

Greaves, Peter;
Williams, Andrew;
Eve, Malcolm

Publication type:

Article

From the analyst's couch: Betting on biogenerics.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 197, doi. 10.1038/nrd1333

By:

Griffiths, Suzanne

Publication type:

Article

Target validation: Regulating the beat.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 203, doi. 10.1038/nrd1338

By:

Brazil, Melanie

Publication type:

Article

In Brief.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 204, doi. 10.1038/nrd1351
Publication type:: Article

RNA interference: Eight steps to silence.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 204, doi. 10.1038/nrd1340

By:

Frantz, Simon

Publication type:

Article

GPCRs: Family traits.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 202, doi. 10.1038/nrd1335

By:

Kirkpatrick, Peter

Publication type:

Article

Cardiovascular disease: Healing hearts.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 202, doi. 10.1038/nrd1355

By:

Farley, Suzanne

Publication type:

Article

Mining for bioinformatics jobs.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 281, doi. 10.1038/nrd1356

By:

Frantz, Simon

Publication type:

Article

The communication barrier: drug discovery's final frontier?

Published in:: 2004
Publication type:: Editorial

THE STATE OF ION CHANNEL RESEARCH IN 2004.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 239, doi. 10.1038/nrd1361

By:

Ion Channel Questionnaire Participants, The Nature Reviews Drug Discovery

Publication type:

Article